Clinical Trial Update: Subcuteous Methotrexate in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating subcutaneous methotrexate for rheumatoid arthritis, highlighting adverse reactions and potential advantages of the subcutaneous …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Bangladesh Medical University | Conditions: Methotrexate Adverse Reaction, Advantage of Using Subcutaneous Route for Methotrexate | Phase 4 | Status: COMPLETED